At a glance
The selected primary study is an acute, controlled human physiology experiment. Its direct findings concern one meal and hormone measurements.
Identity & scope
GHRP-2 is a synthetic GH secretagogue used to investigate ghrelin-related physiology. The cited experiment used a defined research preparation.
What the research shows
- The appetite endpoint is particularly relevant when interpreting a metabolism category: metabolism research can include greater food intake.
Critical interpretation
An acute appetite finding is more specific than a metabolism claim
The seven-man experiment directly measured food eaten during a controlled meal. Its strongest conclusion concerns acute intake under those conditions. The later three-visit study included lean and obese participants and again found increased intake. This extends the population studied, while retaining a short laboratory time window. Neither paper follows the adaptive changes in intake, expenditure and behaviour that determine longer-term body weight. [1] [2]
How to read the meal-study design
The expanded experiment used randomised, double-blind comparisons, a fixed breakfast and a subsequent buffet. Those controls help attribute differences in that meal to the intervention rather than obvious differences in meal availability. They do not make the buffet a measure of sustained nutrition or patient benefit. The observation that fullness afterwards was similar also cautions against translating one appetite rating into a general account of eating behaviour. The relevant endpoint here is greater food intake, not fat loss or improved muscle function. [2]
Limitations & uncertainties
- The small male sample limits generalisability.
- A single meal does not show a sustained change in weight, body composition or performance. Supplied-product identity and quality remain separate questions.
Open research questions
- Would a follow-up study measure sustained intake, energy expenditure, body composition or functional outcomes?
- Does the intended model match the population and exposure in the cited experiment?
Selected papers & source records
Download bibliography1. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men (opens in a new tab)
Laferrère B, Abraham C, Russell CD, Bowers CY. (2005). Journal of Clinical Endocrinology & Metabolism. DOI: 10.1210/jc.2004-1719 (opens in a new tab) · PMID 15699539
- Design & population
- Acute controlled experiment comparing GHRP-2 with saline in seven lean healthy men, followed by a buffet meal.
- What the study found
- Participants consumed more food during GHRP-2 exposure, and circulating GH increased.
- Limits on interpretation
- Seven participants and a single meal cannot establish sustained weight change, muscle growth or long-term safety.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
2. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake (opens in a new tab)
Laferrère B, Hart AB, Bowers CY. (2006). Obesity. DOI: 10.1038/oby.2006.121 (opens in a new tab) · PMID 16861611
- Design & population
- Double-blind randomized three-visit experiment in 19 healthy weight-stable participants, including 10 lean and 9 obese people; GHRP-2 exposures were compared with placebo.
- What the study found
- Food intake increased with GHRP-2 exposure in both lean and obese participants. Greater appetite before the meal did not translate into greater fullness afterwards.
- Limits on interpretation
- Acute controlled-meal research. It does not establish long-term energy balance, sustained weight change or an obesity treatment.
Original source (opens in a new tab) · Full text at publisher / archive (opens in a new tab)
Search & review scope
Targeted web searches of PubMed-indexed primary research and original journal records. Selected abstracts and citation metadata were checked; full-text sections were consulted for the records explicitly labelled full-text. Retrieved records and targeted notice searches were also checked for visible corrections or retractions.. Checked 9 November 2026.
Selected primary research relevant to the named compound, its molecular specification and the endpoints described below.
Narrative selection, not a systematic review, comprehensive safety assessment or complete retraction audit. PubMed/PMC full-text access was intermittent. An abstract or selected-section review cannot replace appraisal of the complete methods, supplements and underlying data. Absence from this selection does not establish absence of research.
Recorded search terms
- site.pubmed.ncbi.nlm.nih.gov/15699539/ (direct record check)
- site.pubmed.ncbi.nlm.nih.gov GHRP-2 chronic infusion food intake human randomized
- "Obese Subjects Respond" "GHRP-2" Laferrere DOI
Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.
Cite this review
HeartPep. GHRP-2: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/ghrp-2.
HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.
Buy from HeartPep.com
Laboratory research only. Not for human or veterinary use.